In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4483-4485

  Verweij, Paul E ^a   Te Dorsthorst, Debbie T A ^a,b   Janssen, Willem H P ^a   Meis, Jacques F G M ^b   Mouton, Johan W ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE MODELS, ANIMAL; FEMALE; FLUCYTOSINE; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME;

EID: 57049145983     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00491-08     Document Type: Article

References (13)

1. Böhme, A., M. Ruhnke, D. Buchheidt, M. Karthaus, H. Einsele, S. Guth, G. Heussel, C. P. Heussel, C. Junghanss, W. K. Kern, T. Kubin, G. Maschmeyer, O. Sezer, G. Silling, T. Südhoff, H. Szelényi Dagger, and A. J. Ullmann. 2003. Treatment of fungal infections in hematology and oncology - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann. Hematol. 82(Suppl. 2):S133-S140.
2. Brèthes, D., C. Napias, E. Torchut, and J. Chevallier. 1992. Purine-cytosine permease of Saccharomyces cerevisiae. Effect of external pH on nucleobase uptake and binding. Eur. J. Biochem. 210:785-791.
3. Forêt, M., R. Schmidt, and U. Reichert. 1978. On the mechanism of substrate binding in the purine-transport system of Saccharomyces cerevisiae. Eur. J. Biochem. 82:33-43.
4. Griffin, D. H. 1994. Nutrient acquisition: digestion and transport, p. 159-188. In D. H. Griffin (ed.), Fungal physiology. Wiley-Liss, New York, NY.
5. Kirby, A., I. Hassan, and J. Burnie. 2006. Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature. J. Infect. 52:405-414.
6. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
7. Polak, A., and M. Grenson. 1973. Evidence for a common transport system for cytosine, adenine and hypoxanthine in Saccharomyces cerevisiae and Candida albicans. Eur. J. Biochem. 32:276-282.
8. te Dorsthorst, D. T. A., J. W. Mouton, C. J. P. van den Beukel, H. A. L. van der Lee, J. F. G. M. Meis, and P. E. Verweij. 2004. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates. Antimicrob. Agents Chemother. 48:3147-3150.
9. te Dorsthorst, D. T. A., P. E. Verweij, J. F. G. M. Meis, and J. W. Mouton. 2005. Efficacy and pharmacodynamics of flucytosine monotherapy in a non-neutropenic murine model of invasive aspergillosis. Antimicrob. Agents Chemother. 49:4220-4226.
10. Vermes, A., H.-J. Guchelaar, and J. Dankert. 2000. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46:171-179.
11. Verweij, P. E., J. P. Donnelly, B. J. Kullberg, J. F. Meis, and B. E. De Pauw. 1994. Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients. Infection 22:81-85.
12. Viviani, M. A., M. C. Esposto, M. Cogliati, and A. M. Tortorano. 2003. Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome? J. Chemother. 15:124-128.
13. Walsh, T. J., E. J. Anaissie, D. W. Denning, R. Herbrecht, D. P. Kontoyiannis, K. A. Marr, V. A. Morrison, B. H. Segal, W. J. Steinbach, D. A. Stevens, J. A. van Burik, J. R. Wingard, T. F. Patterson, et al. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327-360.